Kc UK. Here to help, support and inform on all matter relating to kidney cancer.

kcuk.org.uk

What’s new on Kcuk.org.uk: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Kcuk.org.uk popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Kc UK

  • 93 percent had tumor growth controlled for median of more than 8 months, researchers report WEDNESDAY, Nov. 30, 2016 (HealthDay News) — An experimental drug may show promise in treating kidney cancer, researchers say. The drug CB-839 is the first to...

  • Some Advanced Kidney Cancer Patients May Postpone Treatment: MedlinePlus Some Advanced Kidney Cancer Patients May Postpone Treatment In cases of slow-growing disease, toxic drugs can sometimes be avoided for many months, study finds By Robert Preidt...

  • Two new kidney cancer drugs ‘work’ 26 September 2015 From the section Health Two new therapies for hard to treat advanced kidney cancer could change treatment of the disease, say experts at the European Cancer Congress. Both drugs increased survival...

  • Results of Phase III Clinical Study of Advanced Kidney Cancer Patients after Surgery Revealed No Survival Benefit for Sunitinib, Sorafenib

  • An immunotherapy drug has been described as a potential “game-changer” in promising results presented at the European Cancer Congress. In a study of head and neck cancer, more patients taking nivolumab survived for longer compared with those who were...

You may also like

Home

Managing Myeloma is an educational initiative dedicated to developing tools, information, and resources that support improved ther...

True Engrossment of Reader is Real Profession of...

True Engrossment of Reader is Real Profession of a Writer.

Kcuk.org.uk popular pages

Some worthy website to observe next

Website parameters

  • 8 years

    Domain age

  • N/A

    Visit duration

  • 252

    Daily visitors

  • N/A

    Bounce rate